Post Transplantation Patients
Conditions
Brief summary
As primary endpoint the C-max and the area under the concentration-time curve (AUC)(0-12) of MPA will be calculated. Comparisons will be made between the three formulations in AUC according to the criteria for demonstrating bio-equivalence.
Interventions
DRUGPantoprazole Teva 40 mg maagsapresistente tabletten
DRUGMycophenolate mofetil Sandoz 500 mg Film-coated Tablets
DRUGMycophenolate Mofetil Accord 500 mg plėvele dengtos tabletės
Sponsors
Leids Universitair Medisch Centrum (LUMC)
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As primary endpoint the C-max and the area under the concentration-time curve (AUC)(0-12) of MPA will be calculated. Comparisons will be made between the three formulations in AUC according to the criteria for demonstrating bio-equivalence. | — |
Countries
Netherlands
Outcome results
None listed